University of Illinois Chicago
Explore the effect of MedDiet vs. Usual Diet on circulating and breast tumor fatty acid profiles. The investigators aim to examine impact on tumor biology in newly diagnosed participants.
Conduct a 3-week presurgical window trial among 30 women with stage I-III luminal breast cancer. Participants will be randomized 1:1 to a controlled MedDiet or an enhanced usual-care control. This study will generate critical translational data on how dietary fat composition influences tumor metabolism and immune response, informing future diet-based cancer interventions.
Inclusion Criteria: 1. Age ≥ 18 years; 2. Newly diagnosed stage I-III luminal breast cancer 3. Planned surgical resection at UI Health 4. Ability to speak, read, write, and understand English 5. A Mediterranean Eating Pattern for Americans (MEPA-III) score \<13 indicating that they do not currently follow a MedDiet; 6. ECOG performance status of 0 or 1. Exclusion Criteria: 1. Currently following a MedDiet, vegan diet, or dietary restrictions (e.g., religious, food intolerance/allergy) that preclude adoption of a MedDiet; 2. Lack of access to a space to safely store and reheat foods items; 3…
Fatty acid profile (chain length and degree of saturation) in circulation of blood, tumor tissue, and tumor interstitial fluid.
Fatty acid profile (chain length and degree of saturation) in breast tumor tissue.
Lipid availability in blood, tumor tissue, and tumor interstitial fluid.
Tumor tissue will explore the effect of MedDiet vs. Usual Diet on tumor proliferation (Ki67) and expression of NK and CD8 T cells and chylomicrons (Apo48 staining).
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.